UY28622A1 - QUINOLONA ANTIBACTERIAL AGENTS - Google Patents
QUINOLONA ANTIBACTERIAL AGENTSInfo
- Publication number
- UY28622A1 UY28622A1 UY28622A UY28622A UY28622A1 UY 28622 A1 UY28622 A1 UY 28622A1 UY 28622 A UY28622 A UY 28622A UY 28622 A UY28622 A UY 28622A UY 28622 A1 UY28622 A1 UY 28622A1
- Authority
- UY
- Uruguay
- Prior art keywords
- antibacterial agents
- iii
- formula
- quinolona
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describen compuestos de fórmula I, II, III, v, V y VI y procedimientos para su preparación. Tambie´n se describen procedimientos para fabricar compuestos biológicamente activos de fórmula I, II, III, IV, V y VI a´sí como composiciones farmacéuticamente aceptables que comprenden compuestos de fórmula I, II, III, IV, V y VI. Los compuestos de fórmula I, II, III, IV, V y VI, como se describen en este documento, pueden usarse en diversas aplicaciones incluyendo su uso como agentes antibacterianos.Compounds of formula I, II, III, v, V and VI and processes for their preparation are described. Methods for manufacturing biologically active compounds of formula I, II, III, IV, V and VI therein are also described as pharmaceutically acceptable compositions comprising compounds of formula I, II, III, IV, V and VI. The compounds of formula I, II, III, IV, V and VI, as described herein, can be used in various applications including their use as antibacterial agents.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52307103P | 2003-11-18 | 2003-11-18 | |
| US60549604P | 2004-08-31 | 2004-08-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY28622A1 true UY28622A1 (en) | 2005-06-30 |
Family
ID=34623167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY28622A UY28622A1 (en) | 2003-11-18 | 2004-11-17 | QUINOLONA ANTIBACTERIAL AGENTS |
Country Status (6)
| Country | Link |
|---|---|
| AR (1) | AR046638A1 (en) |
| NL (1) | NL1027545C2 (en) |
| PE (1) | PE20050582A1 (en) |
| TW (1) | TW200524930A (en) |
| UY (1) | UY28622A1 (en) |
| WO (1) | WO2005049602A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ545472A (en) | 2003-09-10 | 2009-09-25 | Kyorin Seiyaku Kk | 7-(4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl)quinolonecarboxylic acid derivative |
| EP2468752A1 (en) | 2005-08-04 | 2012-06-27 | Sirtris Pharmaceuticals, Inc. | Thiazolopyridine derivatives as sirtuin-modulators |
| DE102006005861A1 (en) * | 2006-02-09 | 2007-08-23 | Aicuris Gmbh & Co. Kg | Substituted quinolones III |
| AU2007339692B2 (en) * | 2007-01-05 | 2012-01-19 | Daiichi Sankyo Company, Limited | Fused substituted aminopyrrolidine derivative |
| CN101622240B (en) * | 2007-01-05 | 2014-07-23 | 第一三共株式会社 | Fused substituted aminopyrrolidine derivative |
| CA2688008A1 (en) | 2007-05-24 | 2008-11-27 | Kyorin Pharmaceutical Co., Ltd. | Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position |
| DE102007036068A1 (en) * | 2007-08-01 | 2009-02-05 | Wacker Chemie Ag | Process for the preparation of alkylmethoxymethyltrimethylsilanylmethylamines |
| RU2490257C2 (en) | 2008-05-30 | 2013-08-20 | Такеда Фармасьютикал Компани Лимитед | Heterocyclic compound |
| CA2751695C (en) | 2009-02-06 | 2017-11-28 | Nippon Shinyaku Co., Ltd. | Aminopyrazine derivatives and medicines |
| AR091858A1 (en) | 2012-07-25 | 2015-03-04 | Sova Pharmaceuticals Inc | CISTATIONIN-g-LIASA INHIBITORS (CSE) |
| PE20180252A1 (en) | 2015-06-09 | 2018-02-02 | Bayer Pharma AG | ALOSTERIC POSITIVE MODULATORS OF THE MUSCARINIC RECEIVER M2 |
| WO2018011017A1 (en) | 2016-07-11 | 2018-01-18 | Bayer Pharma Aktiengesellschaft | 7-substituted 1-pyridyl-naphthyridine-3-carboxylic acid amides and use thereof |
| EP3296298A1 (en) | 2016-09-14 | 2018-03-21 | Bayer Pharma Aktiengesellschaft | 7-substituted 1-aryl-naphthyridin-3-carboxamides and their use |
| JOP20190045A1 (en) | 2016-09-14 | 2019-03-14 | Bayer Ag | 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof |
| EP3519392A1 (en) | 2016-09-29 | 2019-08-07 | Bayer CropScience Aktiengesellschaft | Novel 5-substituted imidazole derivatives |
-
2004
- 2004-11-05 WO PCT/IB2004/003666 patent/WO2005049602A1/en active Application Filing
- 2004-11-16 PE PE2004001119A patent/PE20050582A1/en not_active Application Discontinuation
- 2004-11-17 UY UY28622A patent/UY28622A1/en not_active Application Discontinuation
- 2004-11-17 TW TW093135213A patent/TW200524930A/en unknown
- 2004-11-18 AR ARP040104261A patent/AR046638A1/en unknown
- 2004-11-18 NL NL1027545A patent/NL1027545C2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200524930A (en) | 2005-08-01 |
| NL1027545A1 (en) | 2005-05-23 |
| WO2005049602A1 (en) | 2005-06-02 |
| AR046638A1 (en) | 2005-12-14 |
| NL1027545C2 (en) | 2006-01-17 |
| PE20050582A1 (en) | 2005-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0507653A (en) | imidazopyridine derivatives and imidazopyridine pharmaceutical formulation comprising the same and use | |
| UY27760A1 (en) | NEW DERIVATIVES OF PIRROLIDINIO. | |
| UY28622A1 (en) | QUINOLONA ANTIBACTERIAL AGENTS | |
| UY28514A1 (en) | NEW COMPOUNDS | |
| CR8559A (en) | PIRAZOLOPIRIMIDINAS | |
| UY28513A1 (en) | NEW COMPOUNDS | |
| UY29795A1 (en) | ADENINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS | |
| UY27571A1 (en) | 2-TIO-3, 5-DICIAN-4-PHENYL-6-REPLACED AMINOPIRIDINS AND THEIR USE | |
| DOP2002000433A (en) | 2-TIO-3,5-DICIANO-4-FENIL-6-SUBSTITUTED AMINOPIRIDINS AND THEIR USE | |
| AR048878A1 (en) | TOPIC COMPOSITIONS OF METADONA AND METHODS FOR USE | |
| ECSP034774A (en) | PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS | |
| ECSP034773A (en) | PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS | |
| BRPI0212137A2 (en) | dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions | |
| UY30327A1 (en) | NEW COMPOUNDS II | |
| UY28510A1 (en) | CHEMICAL COMPOUNDS | |
| UY29420A1 (en) | DERIVATIVES OF 2-PIRIDONA, COMPOSITIONS THAT CONTAIN THEM, PREPARATION AND APPLICATION PROCESSES | |
| CL2003002770A1 (en) | COMPOUNDS DERIVED FROM PIRROL AND IMIDDAZOL; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM; PREPARATION PROCEDURE; AND ITS USE IN THE TREATMENT AND / OR PREVENTION OF DISEASES THAT ARE ASSOCIATED WITH THE MODULATION OF CANABINOID RECEPTORS | |
| UY30544A1 (en) | PIRROLO-PIPERIDINE COMPOUNDS AND PHARMACEUTICAL SALTS ACCEPTABLE OF THE SAME, MANUFACTURING PROCESSES, COMPOSITIONS AND APPLICATIONS | |
| UY31334A1 (en) | 3A, 4,5,6,7,7A-HEXAHIDRO-3H-BENZOIMIDAZOL AND DERIVAODS OF 3A, 4,5,6,, 7,7A-HEXAHIDRO-3-INDOL, ENANTIOMERS, DIASTEREOISOMERS, PHARMACEUTICALLY ACCEPTED SALTS, MIXTURES, COMPOSITIONS , PREPARATIONS AND APPLICATIONS OF THE SAME | |
| UY28694A1 (en) | NEW COMPOUNDS | |
| UY29234A1 (en) | ADAMANTAN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, BOTH PREPARATION PROCEDURES AND APPLICATIONS. | |
| UY28536A1 (en) | DERIVATIVES OF BENCIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATION AND USES OF THE SAME. | |
| UY29892A1 (en) | NEW CHROMAN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS | |
| CL2004001678A1 (en) | COMPOUNDS DERIVED FROM OXAZOLIDINONA; PHARMACEUTICAL COMPOSITION; AND USE OF COMPOUNDS AS BACTERIAL AGENTS. | |
| ECSP066275A (en) | PYRIDINYLANILIDS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20150525 |